Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, June 18, 2024
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
[ Tue, Jun 18th 2024
] - WOPRAI
Mon, June 17, 2024
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
Joseph Pantginis Reiterated (ATNM) at Strong Buy and Held Target at $50 on, Jun 17th, 2024
Joseph Pantginis of HC Wainwright & Co., Reiterated "Actinium Pharmaceuticals, Inc." (ATNM) at Strong Buy and Held Target at $50 on, Jun 17th, 2024.
Joseph has made no other calls on ATNM in the last 4 months.
There are 3 other peers that have a rating on ATNM. Out of the 3 peers that are also analyzing ATNM, 0 agree with Joseph's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Joseph
- Sudan Loganathan of "Stephens & Co." Initiated at Buy and Held Target at $25 on, Tuesday, May 14th, 2024
- Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $21 on, Tuesday, April 30th, 2024
- Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $30 on, Tuesday, March 19th, 2024
